The US contributes significantly to the growth of the defibrillator market in North America. The U. S. is expected to contribute significantly due to rise in adoption of innovative defibrillator technology. Hospitals and clinics in the U. S. are equipped with latest defibrillation devices and applications, which are essential to perform critical cardiac arrest. Cleveland Clinic, Mayo Clinic, New York-Presbyterian University Hospital of Columbia, and Cornell are some of the key hospitals contributing to the growth of defibrillator market.
Further, there are organizations such as Oklahoma Health Care Authority (OHCA) and Indiana Health Care Association (IHCA) for public health in the US. Each year, over 350,000 emergency medical services-assessed out-of-hospital cardiac arrests occur in the US. CARES, a non-profit organization, designed to help emergency medical services (EMS) agencies, evaluates and improves their performance in cardiac arrest response, and monitors and reports data on patients who received EMS treatment (CPR and/or defibrillation). As a result, the total incidence reported by each database ranges from approximately 180,000 to 395,000 cases.
According to Center for Disease Control & Prevention (CDC), the U. S. national healthcare expenditure was around $3 trillion in 2014. The U. S. has the highest healthcare spending across the globe. In the U. S., the per capita healthcare expenditure per person in 2014 was around $9,523. The North American market has the highest contribution from the US due to significant development in defibrillator market and presence of world's finest hospitals. The U. S. has a considerable contribution in defibrillator market, however rise in medical tourism and high cost of implantable defibrillation may affect the growth of defibrillator market in the U. S.
The Report Covers
- Comprehensive research methodology of the US Defibrillators market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the US Defibrillators market.
- Insights about market determinants which are stimulating the US Defibrillators market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.
Key Topics Covered:
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
5. Market Segmentation
5.1. US Defibrillators Market by Type
5.1.1. Implantable Cardioverter Defibrillators
5.1.2. External Cardioverter Defibrillators
5.2. US Defibrillators Market by End-Users
5.2.2. Ambulatory Services and Others
6. Company Profiles
6.1. Abbott Laboratories, Inc.
6.2. Biotronik SE & Co. KG
6.3. Cintas Corp.
6.4. Defibtech, LLC
6.5. General Electric Co.
6.6. Koninklijke Philips N.V.
6.7. LivaNova PLC
6.8. Medtronic PLC
6.9. Mindray Medical International Co. Ltd.
6.10. Nihon Kohden Corp.
6.11. Stryker Corp.
6.12. ZOLL Medical Corp. (an Asahi Kasei Group company)
For more information about this report visit https://www.researchandmarkets.com/r/shxqm9